Tamsulosin Hydrochloride Capsule
Product Images NDC 72603-115

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 72603-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Tamsulosin Fig1)

This text describes a graph, labeled as Figure 1, which shows the mean plasma concentrations of Tamsulosin Hydrochloride following the administration of Tamsulosin Hydrochloride Capsules at a dose of 0.4 mg under both fasted and fed conditions. The graph shows the plasma concentrations over time, with time marked in hours and the plasma concentration in ng/mL. The graph has two lines, one for the fasted state and one for the fed state, and is based on data obtained from a sample size of 8 individuals.*

FDA Label Image

Figure (Tamsulosin Fig2)

FDA Label Image

Figure (Tamsulosin Fig3)

This is a graph showing the mean change from baseline in Total AUA Symptom Score (0 to 35) for two different treatments. One treatment is shown as "00008my_ -A-/s-A0.4mg" and the other is "Placebo". The graph shows the mean change at various time points during the study, with the x-axis showing the duration of treatment in weeks.*

FDA Label Image

Figure (Tamsulosin Fig4)

This is a statistical summary of a study that evaluated the mean increase in peak urine flow rate in ml/sec. The study had two treatment groups: one received 2.54 mg of a medication (with an unclear name due to errors) while the other received a placebo. The study lasted for 13 weeks and involved 154 participants. The results show that the group that received the medication had a higher increase in peak urine flow rate (3.09 mL/sec) compared to the placebo group (2.04 mL/sec). The mean change in urine flow rate was 1.04 musec.*

FDA Label Image

Figure (Tamsulosin Fig5)

The text shows a figure labeled as 3B representing a study involving two treatments: 0.8 mg-A-A-0.4 mpTrCY and Placebo. It also displays the mean increase in peak urine flow rate measured in mL/Sec. The study had a duration of weeks and had several participants (n) in different groups depending on the treatment. There is also a chart showing the Mean Change over time. However, the data seems incomplete and specific details about the study are not available.*

FDA Label Image

Package Label-principal Display Panel (0.4 mg (100 Capsules Bottle))

Each capsule contains 0.4mg of Tamsulosin hydrochloride USP. They are manufactured by Northstar Rx LLC and should be stored at 20° to 25°C. The usual dosage should be obtained from the accompanying prescribing information. The capsules should be kept away from excessive moisture and dispensed in a tight container. The M.L. number is 22/MN/AP/2009/F/R and they come in a pack of 100 capsules. The product is from India and the expiry date and lot number are located in the coding area.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.